
Kristin Hunt Karner, MD
Medical Director: Hematopathology and Molecular Oncology
Associate Professor (Clinical), University of Utah School of Medicine
Education
- Medical Degree—University of Nebraska
- Residency—Anatomic and Clinical Pathology, University of New Mexico
- Fellowship—Hematopathology, University of New Mexico
- Fellowship—Molecular Genetic Pathology, University of New Mexico
Current/Past Roles
- Senior Staff Pathologist, Henry Ford Health System, Detroit, MI (2010-2017)
Certification/Affiliations
- American Board of Pathology (Anatomic and Clinical Pathology, Hematopathology, Molecular Genetic Pathology)
Research Interests
- Lymphoid and myeloid malignancies
- Genetic aspects of myelodysplastic syndrome and other myeloid malignancies
Publications
- Ng DP, et al. BCR-ABL1 (p210) transcript kinetics. Arch Pathol Lab Med. 2022;146(9):1140–43.
- Ganapathi KA, et al. Peripheral T-cell lymphomas of the T follicular helper type: clinical, pathological and genetic attributes. Hemato. 2022;3(1):268–86.
- Karner KH, et al. Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods. Int J Lab Hematol. 2020;42(2):e35–e37.
- Schumacher JA, et al. Detection and quantification of FLT3 internal tandem duplication mutations do not vary significantly between whole blood and blast-enriched samples. Am J Clin Pathol. 2020;153(2):251–7.
- Karner KH, et al. Current aspects of clonal hematopoeisis: implications for clinical diagnosis. Ann Lab Med. 2019;39(6):509–14.